Clinical trial10 patients · first-in-human pilot trial
First-in-human trial of atrial fibrillation ablation using real-time tissue optical assessment to predict pulsed field lesion durability
After pulsed field ablation the bipolar electrograms disappear, so it is hard to judge right away how durable the resulting lesion is. In patients with paroxysmal atrial fibrillation, the authors tested for the first time in humans a new system that shows structural changes in the tissue optically during ablation, and checked the result with repeat mapping after 3 months. Lesions at sites where the optical signal dropped by more than a certain threshold proved durable; no serious adverse events related to the system were recorded.
- Authors
- Raphael P. Martins, Giorgi Papiashvili, Askar Sabirov, Sherzod Sabirov, David Herranz, Christophe Bailleul, Atul Verma
- Sherzod Sabirov's position
- author 4 of 7
- Affiliation
- Ezgu Niyat Medical Center, Tashkent, Uzbekistan
- Published in
- Europace. 2025;27(2):euaf009. doi:10.1093/europace/euaf009
Funding and conflicts of interest: The study was sponsored and funded by MedLumics. The authors’ statements on conflicts of interest are given in the article itself.
Full text in English · Open access · CC BY-NC 4.0